Cargando…

Persistent hepatocyte apoptosis promotes tumorigenesis from diethylnitrosamine-transformed hepatocytes through increased oxidative stress, independent of compensatory liver regeneration

Hepatocellular carcinoma highly occurs in chronic hepatitis livers, where hepatocyte apoptosis is frequently detected. Apoptosis is a mechanism that eliminates mutated cells. Hepatocyte apoptosis induces compensatory liver regeneration, which is believed to contribute to tumor formation. Hepatocyte-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nozaki, Yasutoshi, Hikita, Hayato, Tanaka, Satoshi, Fukumoto, Kenji, Urabe, Makiko, Sato, Katsuhiko, Myojin, Yuta, Doi, Akira, Murai, Kazuhiro, Sakane, Sadatsugu, Saito, Yoshinobu, Kodama, Takahiro, Sakamori, Ryotaro, Tatsumi, Tomohide, Takehara, Tetsuo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7873060/ https://www.ncbi.nlm.nih.gov/pubmed/33564095 http://dx.doi.org/10.1038/s41598-021-83082-7

Ejemplares similares

Constitutive Activation of the Tumor Suppressor p53 in Hepatocytes Paradoxically Promotes Non–Cell Autonomous Liver Carcinogenesis
por: Makino, Yuki, et al.
Publicado: (2022)

Hyperglycemia enhances pancreatic cancer progression accompanied by elevations in phosphorylated STAT3 and MYC levels
por: Sato, Katsuhiko, et al.
Publicado: (2020)

Activation of p53 After Irradiation Impairs the Regenerative Capacity of the Mouse Liver
por: Urabe, Makiko, et al.
Publicado: (2021)

White Adipose Tissue Autophagy and Adipose-Liver Crosstalk Exacerbate Nonalcoholic Fatty Liver Disease in Mice
por: Sakane, Sadatsugu, et al.
Publicado: (2021)

Pentraxin 3 is an adipose tissue‐related serum marker for pancreatic cancer cachexia predicting subsequent muscle mass and visceral fat loss
por: Sato, Katsuhiko, et al.
Publicado: (2022)

Hepatocellular Carcinoma in a Patient with Tetralogy of Fallot: A Case Report and Literature Review
por: Hyun Sung, Ji, et al.
Publicado: (2021)

CRISPR Loss-of-Function Screen Identifies the Hippo Signaling Pathway as the Mediator of Regorafenib Efficacy in Hepatocellular Carcinoma
por: Suemura, Shigeki, et al.
Publicado: (2019)

Capsid Allosteric Modulators Enhance the Innate Immune Response in Hepatitis B Virus–Infected Hepatocytes During Interferon Administration
por: Fukutomi, Keisuke, et al.
Publicado: (2021)

Fucosylated haptoglobin is a novel predictive marker of hepatocellular carcinoma after hepatitis C virus elimination in patients with advanced liver fibrosis
por: Shirai, Kumiko, et al.
Publicado: (2022)

Serum amyloid P component and pro-platelet basic protein in extracellular vesicles or serum are novel markers of liver fibrosis in chronic hepatitis C patients
por: Shirai, Kumiko, et al.
Publicado: (2022)

Hepatitis C virus enhances Rubicon expression, leading to autophagy inhibition and intracellular innate immune activation
por: Shiode, Yuto, et al.
Publicado: (2020)

TNF receptor–related factor 3 inactivation promotes the development of intrahepatic cholangiocarcinoma through NF‐κB‐inducing kinase–mediated hepatocyte transdifferentiation
por: Shiode, Yuto, et al.
Publicado: (2023)

STAT3 is Activated by CTGF-mediated Tumor-stroma Cross Talk to Promote HCC Progression
por: Makino, Yuki, et al.
Publicado: (2022)

Thrombospondin-2 as a Predictive Biomarker for Hepatocellular Carcinoma after Hepatitis C Virus Elimination by Direct-Acting Antiviral
por: Matsumae, Takayuki, et al.
Publicado: (2023)

Improvement of Skeletal Muscle Mass after Ledipasvir and Sofosbuvir Treatment for Hepatitis C Virus in Decompensated Liver Cirrhosis
por: Sakamori, Ryotaro, et al.
Publicado: (2021)

Transcriptomics Identify Thrombospondin‐2 as a Biomarker for NASH and Advanced Liver Fibrosis
por: Kozumi, Kazuhiro, et al.
Publicado: (2021)

Increased Bcl-xL Expression in Pancreatic Neoplasia Promotes Carcinogenesis by Inhibiting Senescence and Apoptosis
por: Ikezawa, Kenji, et al.
Publicado: (2017)

Sodium taurocholate cotransporting polypeptide inhibition efficiently blocks hepatitis B virus spread in mice with a humanized liver
por: Nakabori, Tasuku, et al.
Publicado: (2016)

Interleukin-6 Is a Circulating Prognostic Biomarker for Hepatocellular Carcinoma Patients Treated with Combined Immunotherapy
por: Myojin, Yuta, et al.
Publicado: (2022)

Pre-existing minor variants with NS5A L31M/V-Y93H double substitution are closely linked to virologic failure with asunaprevir plus daclatasvir treatment for genotype 1b hepatitis C virus infection
por: Morishita, Naoki, et al.
Publicado: (2020)

The First Case of Coil Embolization for Left Gastric Vein Aneurysm with Liver Cirrhosis: A Case Report and Review of the Literature
por: Kato, Seiya, et al.
Publicado: (2021)

Caspase-3 suppresses diethylnitrosamine-induced hepatocyte death, compensatory proliferation and hepatocarcinogenesis through inhibiting p38 activation
por: Shang, Na, et al.
Publicado: (2018)

Evaluation of Fucosylated Haptoglobin and Mac-2 Binding Protein as Serum Biomarkers to Estimate Liver Fibrosis in Patients with Chronic Hepatitis C
por: Tawara, Seiichi, et al.
Publicado: (2016)

Circulating Cell-Free DNA Profiling Predicts the Therapeutic Outcome in Advanced Hepatocellular Carcinoma Patients Treated with Combination Immunotherapy
por: Matsumae, Takayuki, et al.
Publicado: (2022)

Hepatitis C virus infection suppresses hepatitis B virus replication via the RIG-I-like helicase pathway
por: Murai, Kazuhiro, et al.
Publicado: (2020)

Liver Fibrosis Is Associated With Corrected QT Prolongation During Ledipasvir/Sofosbuvir Treatment for Patients With Chronic Hepatitis C
por: Tahata, Yuki, et al.
Publicado: (2018)

CEACAM1 Is Associated With the Suppression of Natural Killer Cell Function in Patients With Chronic Hepatitis C
por: Suda, Takahiro, et al.
Publicado: (2018)

Dietary fructose enhances the incidence of precancerous hepatocytes induced by administration of diethylnitrosamine in rat
por: Kumamoto, Ryo, et al.
Publicado: (2013)

Development of altered hepatocyte foci by separate and combined treatments with radiation and diethylnitrosamine in neonatal rats.
por: Kim, S. H., et al.
Publicado: (1994)

Disturbance of the Cell Cycle with Colchicine Enhances the Growth Advantage of Diethylnitrosamine‐initiated Hepatocytes in Rats
por: Tsutsumi, Masahiro, et al.
Publicado: (1996)

Assessment of SENP3-interacting proteins in hepatocytes treated with diethylnitrosamine by BioID assay
por: Chen, Fei, et al.
Publicado: (2021)

Involvement of proliferation of atypical hepatocytes and CDT 1 in the liver cancer of rats administered the diethylnitrosamine
por: Ogawa, Masahiro, et al.
Publicado: (2023)

Frequency and role of NKp46 and NKG2A in hepatitis B virus infection
por: Yoshioka, Teppei, et al.
Publicado: (2017)

Inhibition of nonhomologous end joining‐mediated DNA repair enhances anti‐HBV CRISPR therapy
por: Murai, Kazuhiro, et al.
Publicado: (2022)

The First Transileocolic Obliteration for Refractory Esophageal Varices: A Case Report and Review of the Literature
por: Fujii, Yoshifumi, et al.
Publicado: (2021)

Pretreatment with antibiotics is associated with reduced therapeutic response to atezolizumab plus bevacizumab in patients with hepatocellular carcinoma
por: Maesaka, Kazuki, et al.
Publicado: (2023)

Transcription coactivator PBP/MED1-deficient hepatocytes are not susceptible to diethylnitrosamine-induced hepatocarcinogenesis in the mouse
por: Matsumoto, Kojiro, et al.
Publicado: (2010)

β-Catenin Loss in Hepatocytes Promotes Hepatocellular Cancer after Diethylnitrosamine and Phenobarbital Administration to Mice
por: Awuah, Prince Kwaku, et al.
Publicado: (2012)

The Hepatitis B Virus Genotype Affects the Persistence of Viral Replication in Immunodeficient NOG Mice
por: Yokoyama, Yoshinobu, et al.
Publicado: (2015)

Forkhead Box M1 Transcription Factor Drives Liver Inflammation Linking to Hepatocarcinogenesis in Mice
por: Kurahashi, Tomohide, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_seiki82fsom3v6n361vef46cjj